Fibroblastic disorders

M13_FIBROBLASTIC

fibroma: A non-metastasizing neoplasm arising from the fibrous tissue. It is characterized by the presence of spindle-shaped fibroblasts.

Endpoint definition

FinnGen phenotype data

392423 individuals

diagram downward connector

Apply sex-specific rule None

392423

diagram downward connector

Check conditions None

392423

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 M72
Cause of death: ICD-10 M72

2 out of 7 registries used, show all original rules.

6616

diagram downward connector

Check minimum number of events None

6616

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

7952

diagram downward connector
M13_FIBROBLASTIC

Control definitions

Control exclude M13_SOFTTISSUE

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF2
Parent code in ICD-10 M70-M79
Name in latin Morbositates fibroblasticae

Similar endpoints

List of similar endpoints to Fibroblastic disorders based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Broader endpoints:

Venn diagram with a set fully inside an highlighted set Narrower endpoints:

Show all endpoint correlations

Summary Statistics

Key figures

All Female Male
Number of individuals 7952 3402 4550
Unadjusted prevalence (%) 2.11 1.61 2.74
Mean age at first event (years) 54.12 50.50 56.83

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.02 1.08 [0.83, 1.41] 5.5e-1 1142
15 years 0.01 0.83 [0.67, 1.04] 1.0e-1 564
5 years 0.00 1.10 [0.90, 1.35] 3.6e-1 204
1 year 0.00 1.63 [1.20, 2.22] 2.0e-3 54

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: M13_FIBROBLASTIC – Fibroblastic disorders
GWS hits: 32

Survival analyses between endpoints

Plot

before Fibroblastic disorders
after Fibroblastic disorders

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Fibroblastic disorders

Endpoint not on priority list, no data to show.